Literature DB >> 25748312

Association between tumor necrosis factor inhibitor (TNFi) therapy and changes in C-reactive protein (CRP), blood pressure, and alanine aminotransferase (ALT) among patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis.

Jashin J Wu1, Christopher G Rowan2, Judith D Bebchuk3, Mary S Anthony4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25748312     DOI： 10.1016/j.jaad.2015.02.004

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  2 in total

1.  Usage of C-Reactive Protein Testing in the Diagnosis and Monitoring of Psoriatic Arthritis (PsA): Results from a Real-World Survey in the USA and Europe.

Authors:  A Ogdie; W Tillett; N Booth; O Howell; A Schubert; S Peterson; S D Chakravarty; L C Coates
Journal:  Rheumatol Ther       Date:  2022-01-15

Review 2.  Psoriasis and Co-morbidity.

Authors:  Mina Amin; Erica B Lee; Tsen-Fang Tsai; Jashin J Wu
Journal:  Acta Derm Venereol       Date:  2020-01-30       Impact factor: 3.875
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.